(PubMed) The Diabetes Control and Complications Trial Research Group
Oral research-planning amounts are usually higher than subcutaneous amounts to account for absorption differences
Kovalcsik R, Devlin T, Loux S, Martinek M, May J, Pickering T, et al
BPC 157 is a versatile peptide, which means many people are good candidates for this therapy
Insulin Resistance and Diabetes Zamani et al
This distinction is exactly why Dr Ritus feature in The Australian warned against GHK copper peptide injections, highlighting that while safe topical treatments offer clinical benefits, unregulated injectables carry severe, unproven risks